Khandaker S, Sharma S, Hall T, Lim S, Lehtonen J, Leung S
J Infect Dis. 2024; 231(2):e456-e467.
PMID: 39692506
PMC: 11841642.
DOI: 10.1093/infdis/jiae607.
Manuel G, Twentyman J, Noble K, Eastman A, Aronoff D, Seepersaud R
Clin Microbiol Rev. 2024; 38(1):e0015422.
PMID: 39584819
PMC: 11905376.
DOI: 10.1128/cmr.00154-22.
Zeng Z, Li M, Zhu S, Zhang K, Wu Y, Zheng M
Front Cell Infect Microbiol. 2024; 14:1396762.
PMID: 39569407
PMC: 11576427.
DOI: 10.3389/fcimb.2024.1396762.
Barazesh M, Abbasi M, Mohammadi M, Nasiri M, Rezaei F, Mohammadi S
Sci Rep. 2024; 14(1):28294.
PMID: 39550419
PMC: 11569170.
DOI: 10.1038/s41598-024-79503-y.
Imperi M, Gherardi G, Alfarone G, Creti R
Pathogens. 2024; 13(9).
PMID: 39338998
PMC: 11434888.
DOI: 10.3390/pathogens13090807.
Incidence of invasive infections with Group B streptococcus in adults in Norway 1996-2019: a nationwide registry-based case-control study.
Uggen E, Olaisen C, Lyng R, Simonsen G, Baevre-Jensen R, Gran F
Infection. 2024; 52(5):1745-1752.
PMID: 38483786
PMC: 11499455.
DOI: 10.1007/s15010-024-02210-3.
Safety and immunogenicity of the group B vaccine AlpN in a placebo-controlled double-blind phase 1 trial.
Gonzalez-Miro M, Pawlowski A, Lehtonen J, Cao D, Larsson S, Darsley M
iScience. 2023; 26(3):106261.
PMID: 36915681
PMC: 10005905.
DOI: 10.1016/j.isci.2023.106261.
Association of infant Rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive Group B Streptococcal disease in young infants.
Dangor Z, Kwatra G, Pawlowski A, Fisher P, Izu A, Lala S
Vaccine. 2023; 41(10):1679-1683.
PMID: 36754766
PMC: 9996286.
DOI: 10.1016/j.vaccine.2023.01.071.
Molecular Epidemiology of Group B Streptococcus Colonization in Egyptian Women.
Shabayek S, Vogel V, Jamrozy D, Bentley S, Spellerberg B
Microorganisms. 2023; 11(1).
PMID: 36677330
PMC: 9861799.
DOI: 10.3390/microorganisms11010038.
The Streptococcus agalactiae R3 surface protein is encoded by sar5.
Basson A, Olaisen C, Selvik L, Lyng R, Lysvand H, Gidon A
PLoS One. 2022; 17(7):e0263199.
PMID: 35905090
PMC: 9337641.
DOI: 10.1371/journal.pone.0263199.
Identifying large-scale recombination and capsular switching events in strains causing disease in adults in the UK between 2014 and 2015.
Basit Khan U, Jauneikaite E, Andrews R, Chalker V, Spiller O
Microb Genom. 2022; 8(3).
PMID: 35290175
PMC: 9176283.
DOI: 10.1099/mgen.0.000783.
A group B alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains.
Pawlowski A, Lannergard J, Gonzalez-Miro M, Cao D, Larsson S, Persson J
Cell Rep Med. 2022; 3(2):100511.
PMID: 35243418
PMC: 8861819.
DOI: 10.1016/j.xcrm.2022.100511.
Immunogenic Proteins of Group B Streptococcus-Potential Antigens in Immunodiagnostic Assay for GBS Detection.
Dobrut A, Brzychczy-Wloch M
Pathogens. 2022; 11(1).
PMID: 35055991
PMC: 8778278.
DOI: 10.3390/pathogens11010043.
C-protein α-antigen modulates the lantibiotic thusin resistance in Streptococcus agalactiae.
Mirkovic N, Obradovic M, OConnor P, Filipic B, Jovcic B, Cotter P
Antonie Van Leeuwenhoek. 2021; 114(10):1595-1607.
PMID: 34319449
DOI: 10.1007/s10482-021-01626-3.
Vaccines to Prevent Meningitis: Historical Perspectives and Future Directions.
Alderson M, Welsch J, Regan K, Newhouse L, Bhat N, Marfin A
Microorganisms. 2021; 9(4).
PMID: 33917003
PMC: 8067733.
DOI: 10.3390/microorganisms9040771.
A Vaccine Against Group B : Recent Advances.
Carreras-Abad C, Ramkhelawon L, Heath P, Le Doare K
Infect Drug Resist. 2020; 13:1263-1272.
PMID: 32425562
PMC: 7196769.
DOI: 10.2147/IDR.S203454.
Genetic heterogeneity of the Spy1336/R28-Spy1337 virulence axis in Streptococcus pyogenes and effect on gene transcript levels and pathogenesis.
Eraso J, Kachroo P, Olsen R, Beres S, Zhu L, Badu T
PLoS One. 2020; 15(3):e0229064.
PMID: 32214338
PMC: 7098570.
DOI: 10.1371/journal.pone.0229064.
Multistate, Population-Based Distributions of Candidate Vaccine Targets, Clonal Complexes, and Resistance Features of Invasive Group B Streptococci Within the United States, 2015-2017.
McGee L, Chochua S, Li Z, Mathis S, Rivers J, Metcalf B
Clin Infect Dis. 2020; 72(6):1004-1013.
PMID: 32060499
PMC: 8071603.
DOI: 10.1093/cid/ciaa151.
Progress toward a group B streptococcal vaccine.
Song J, Lim J, Lim S, Yong Z, Seo H
Hum Vaccin Immunother. 2018; 14(11):2669-2681.
PMID: 29995578
PMC: 6314413.
DOI: 10.1080/21645515.2018.1493326.
Non-Pilus, Cell Wall-Anchored Proteins: Involvement in Colonization and Pathogenesis and Potential as Vaccine Candidates.
Pietrocola G, Arciola C, Rindi S, Montanaro L, Speziale P
Front Immunol. 2018; 9:602.
PMID: 29686667
PMC: 5900788.
DOI: 10.3389/fimmu.2018.00602.